Merck (MRK) Change in Cash (2009 - 2026)
Merck (MRK) reported Change in Cash of -$9.3 billion for Q1 2026, down 102.62% year-over-year from $355.1 billion in Q1 2025, and down 160.28% on a QoQ basis from -$3.6 billion in Q4 2025.
Merck (MRK) has 18 years of Change in Cash data on file, last reported at -$9.3 billion in Q1 2026.
- Quarterly Change in Cash fell 102.62% year-over-year to -$9.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.3 billion (down 208.92% YoY) and the FY2025 annual result came in at $1.4 billion, down 78.59% from the prior year.
- Change in Cash eased to -$9.3 billion in Q1 2026 per MRK's latest filing, from -$3.6 billion in the prior quarter.
- Across five years, Change in Cash topped out at $10.2 billion in Q3 2025 and bottomed at -$9.3 billion in Q1 2026.
- The 5-year median for Change in Cash is -$659.0 million (2025), against an average of -$162.9 million.
- The widest annual swing landed in 2023, when Change in Cash tumbled 768.23%; it then soared 239.96% in 2024.
- Tracing MRK's Change in Cash over 5 years: stood at $1.5 billion in 2022, then tumbled by 217.8% to -$1.8 billion in 2023, then climbed by 22.16% to -$1.4 billion in 2024, then tumbled by 160.58% to -$3.6 billion in 2025, then tumbled by 160.28% to -$9.3 billion in 2026.
- Per Business Quant, the three latest MRK Change in Cash figures stand at -$9.3 billion (Q1 2026), -$3.6 billion (Q4 2025), and $10.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -1.99 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 1.98 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 4.16 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -9.29 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.91 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 65.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 563.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -635.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.29 Bn |
| Dec 31, 2025 | -3.57 Bn |
| Sep 30, 2025 | 10.19 Bn |
| Jun 30, 2025 | -659.00 Mn |
| Mar 31, 2025 | -4.59 Bn |
| Dec 31, 2024 | -1.37 Bn |
| Sep 30, 2024 | 3.32 Bn |
| Jun 30, 2024 | 5.70 Bn |
| Mar 31, 2024 | -1.24 Bn |
| Dec 31, 2023 | -1.76 Bn |
| Sep 30, 2023 | 2.96 Bn |
| Jun 30, 2023 | -4.07 Bn |
| Mar 31, 2023 | -2.99 Bn |
| Dec 31, 2022 | 1.49 Bn |
| Sep 30, 2022 | 1.53 Bn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 447.00 Mn |
| Dec 31, 2021 | -1.88 Bn |
| Sep 30, 2021 | 1.42 Bn |
| Jun 30, 2021 | 1.62 Bn |
| Mar 31, 2021 | -1.14 Bn |
| Dec 31, 2020 | 764.00 Mn |
| Sep 30, 2020 | -3.75 Bn |
| Jun 30, 2020 | 3.69 Bn |
| Mar 31, 2020 | -2.47 Bn |
| Dec 31, 2019 | 2.06 Bn |
| Sep 30, 2019 | 1.21 Bn |
| Jun 30, 2019 | -1.42 Bn |
| Mar 31, 2019 | 110.00 Mn |
| Dec 31, 2018 | 139.00 Mn |
| Sep 30, 2018 | 2.52 Bn |
| Jun 30, 2018 | 826.00 Mn |
| Mar 31, 2018 | -1.61 Bn |
| Dec 31, 2017 | -1.81 Bn |
| Sep 30, 2017 | 115.00 Mn |
| Jun 30, 2017 | -3.92 Bn |
| Mar 31, 2017 | 5.19 Bn |
| Dec 31, 2016 | -1.39 Bn |
| Sep 30, 2016 | 1.30 Bn |
| Jun 30, 2016 | -3.11 Bn |
| Mar 31, 2016 | 1.19 Bn |
| Dec 31, 2015 | 976.00 Mn |
| Sep 30, 2015 | 626.00 Mn |
| Jun 30, 2015 | -1.06 Bn |
| Mar 31, 2015 | 539.00 Mn |
| Dec 31, 2014 | -3.93 Bn |
| Sep 30, 2014 | 1.63 Bn |
| Jun 30, 2014 | -6.09 Bn |
| Mar 31, 2014 | 207.00 Mn |
| Dec 31, 2013 | 1.53 Bn |
| Sep 30, 2013 | -1.00 Bn |
| Jun 30, 2013 | 2.07 Bn |
| Mar 31, 2013 | -427.00 Mn |
| Dec 31, 2012 | -3.91 Bn |
| Sep 30, 2012 | 608.00 Mn |
| Jun 30, 2012 | 2.10 Bn |
| Mar 31, 2012 | 1.13 Bn |
| Dec 31, 2011 | -722.00 Mn |
| Sep 30, 2011 | 1.91 Bn |
| Jun 30, 2011 | 647.00 Mn |
| Mar 31, 2011 | 795.00 Mn |
| Dec 31, 2010 | 1.03 Bn |
| Sep 30, 2010 | 1.21 Bn |
| Jun 30, 2010 | 430.00 Mn |
| Mar 31, 2010 | -1.08 Bn |
| Dec 31, 2009 | -12.51 Bn |
| Sep 30, 2009 | 9.36 Bn |
| Jun 30, 2009 | 6.44 Bn |
| Mar 31, 2009 | 1.65 Bn |